The business of NORDA ASA (former NorDiag ASA) is research and development, and to offer services and products within the biotechnology sector, including participating in other companies with similar operations, as well as trading with and investing in securities, real estates and other assets.

The Company has May 4, 2012 sold its sample preparation business to DiaSorin. Going forward NORDA ASA will focus on the development of the Colorectal Cancer diagnostic screening test Genefec™.